RecruitingNCT06393920

PulseSelect™ PFA Global Registry

PulseSelect PFA Global Registry, a Part of the Medtronic Cardiac Ablation Post-Market Study Platform

Sponsor

Medtronic Cardiac Ablation Solutions

Enrollment

1,950 participants

Start Date

Jul 23, 2024

Study Type

OBSERVATIONAL

Conditions

Atrial Fibrillation

Summary

The PulseSelect™ PFA Global Registry is a prospective, global, multi-center, observational post-approval study. Subjects will be treated with the PulseSelect™ PFA System and followed according to SOC.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This is a global registry study tracking real-world outcomes for patients who undergo a heart procedure called pulsed field ablation (PFA) using the PulseSelect system — a newer technology for treating atrial fibrillation (irregular heartbeat). It is an observational study, not a drug or experimental device trial. **You may be eligible if...** - You are 18 or older (or meet the minimum age required in your country) - You have been diagnosed with atrial fibrillation (AF) - You are already scheduled to have the PulseSelect PFA procedure as part of your standard care - You are willing to follow study requirements and provide consent **You may NOT be eligible if...** - You are already enrolled in another clinical study that does not allow simultaneous participation in this registry - Local laws in your country exclude you from participation Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(28)

Vancouver General Hospital

Vancouver, British Columbia, Canada

McGill University Health Centre (MUHC)

Montreal, Quebec, Canada

Fuwai Hospital Chinese Academy of Medical Sciences

Beijing, China

The Second Affiliated Hospital of Harbin Medical University

Harbin, China

Nanjing Drum Tower Hospital

Nanjing, China

Ruijin Hospital Shanghai Jiao Tong University School of Medicine

Shanghai, China

Wuhan Asia General Hospital

Wuhan, China

Centre Hospitalier Universitaire de Grenoble - Site Nord

Grenoble, France

Les Hôpitaux de Chartres - Hôpital Louis Pasteur

Le Coudray, France

Hôpital Privé Jacques Cartier

Massy, France

Clinique Pasteur

Toulouse, France

Universitäts Klinikum Frankfurt - Goethe-Universität

Frankfurt, Germany

Universitätsklinikum Heidelberg

Heidelberg, Germany

St. Vincenz Krakenhaus Paderborn

Paderborn, Germany

St. Vincenz-Krankenhaus Paderborn

Paderborn, Germany

Bioclinic Athens

Athens, Greece

IRCCS Ospedale Sacro Cuore Don Calabria

Negrar, Verona, Italy

Azienda Ospedaliera di Ancona

Ancona, Italy

St Antonius Ziekenhuis

Nieuwegein, Netherlands

Seoul National University Bundang Hospital

Seongnam-si, Gyeonggi-do, South Korea

Seoul National University Hospital

Seoul, Seoul, South Korea

Samsung Medical Center

Seoul, South Korea

Severance Hospital

Seoul, South Korea

Hospital Universitario Reina Sofía

Córdoba, Spain

H. Univ. Virgen de la Victoria - Malaga

Málaga, Spain

Complejo Asistencial Universitario de Salamanca

Salamanca, Spain

Basildon and Thurrock University Hospitals

Basildon, United Kingdom

University Hospitals Coventry & Warwickshire

Coventry, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06393920

Related Trials

Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

NCT03907046187 locations

A Study of VARIPULSE Pulsed Field Ablation (PFA) Catheter and FARAWAVE PFA Catheter in the Treatment of Participants With Persistent Atrial Fibrillation

NCT075237501 location

Feasibility Study on the VERAFEYE Imaging and Navigation System for Guided Catheter Ablation Procedures

NCT072712381 location

Anatomical Navigation for Guided Electrophysiology in AFL and AFib

NCT072101511 location

Development of CIRC Technologies

NCT056542721 location